|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
|
4
|
Song S and Ajani JA: The role of microRNAs
in cancers of the upper gastrointestinal tract. Nat Rev
Gastroenterol Hepatol. 10:109–118. 2013. View Article : Google Scholar
|
|
5
|
Ando T, Yoshida T, Enomoto S, Asada K,
Tatematsu M, Ichinose M, Sugiyama T and Ushijima T: DNA methylation
of microRNA genes in gastric mucosae of gastric cancer patients:
Its possible involvement in the formation of epigenetic field
defect. Int J Cancer. 124:2367–2374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kiga K, Mimuro H, Suzuki M,
Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki
YW, Kayo H, et al: Epigenetic silencing of miR-210 increases the
proliferation of gastric epithelium during chronic Helicobacter
pylori infection. Nat Commun. 5:44972014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y,
Liu C, Song W, Wang F, Zhang J, et al: DNA methylation
downregulated mir-10b acts as a tumor suppressor in gastric cancer.
Gastric Cancer. 18:43–54. 2015. View Article : Google Scholar
|
|
8
|
Morita S, Horii T, Kimura M, Ochiya T,
Tajima S and Hatada I: miR-29 represses the activities of DNA
methyltransferases and DNA demethylases. Int J Mol Sci.
14:14647–14658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y,
Qi YT, Xu Q, Li W, Lu B, et al: A regulatory circuit of
miR-148a/152 and DNMT1 in modulating cell transformation and tumor
angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 5:3–13.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: MiR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: A novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar
|
|
11
|
Huang J, Wang Y, Guo Y and Sun S:
Down-regulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
meth-yltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song F, Yang D, Liu B, Guo Y, Zheng H, Li
L, Wang T, Yu J, Zhao Y, Niu R, et al: Integrated microRNA network
analyses identify a poor-prognosis subtype of gastric cancer
characterized by the miR-200 family. Clin Cancer Res. 20:878–889.
2014. View Article : Google Scholar
|
|
13
|
Kurashige J, Mima K, Sawada G, Takahashi
Y, Eguchi H, Sugimachi K, Mori M, Yanagihara K, Yashiro M, Hirakawa
K, et al: Epigenetic modulation and repression of miR-200b by
cancer-associated fibroblasts contribute to cancer invasion and
peritoneal dissemination in gastric cancer. Carcinogenesis.
36:133–141. 2015. View Article : Google Scholar
|
|
14
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davalos V, Moutinho C, Villanueva A, Boque
R, Silva P, Carneiro F and Esteller M: Dynamic epigenetic
regulation of the microRNA-200 family mediates epithelial and
mesenchymal transitions in human tumorigenesis. Oncogene.
31:2062–2074. 2012. View Article : Google Scholar :
|
|
16
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar :
|
|
17
|
Neves R, Scheel C, Weinhold S, Honisch E,
Iwaniuk KM, Trompeter HI, Niederacher D, Wernet P, Santourlidis S
and Uhrberg M: Role of DNA methylation in miR-200c/141 cluster
silencing in invasive breast cancer cells. BMC Res Notes.
3:2192010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yasui W, Sentani K, Sakamoto N, Anami K,
Naito Y and Oue N: Molecular pathology of gastric cancer: Research
and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gigek CO, Chen ES, Calcagno DQ, Wisnieski
F, Burbano RR and Smith MA: Epigenetic mechanisms in gastric
cancer. Epigenomics. 4:279–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv
Y, Fan X, Sang M, Liu XD and Liu W: The downregulation of
miR-200c/141 promotes ZEB1/2 expression and gastric cancer
progression. Med Oncol. 32:4282015. View Article : Google Scholar
|
|
22
|
Mongroo PS and Rustgi AK: The role of the
miR-200 family in epithelial-mesenchymal transition. Cancer Biol
Ther. 10:219–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng X, Wang Z, Fillmore R and Xi Y:
MiR-200, a new star miRNA in human cancer. Cancer Lett.
344:166–173. 2014. View Article : Google Scholar :
|
|
24
|
Paterson EL, Kazenwadel J, Bert AG,
Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of
the miRNA-200 family at the invasive front of colorectal cancers
with degraded basement membrane indicates EMT is involved in cancer
progression. Neoplasia. 15:180–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahn SM, Cha JY, Kim J, Kim D, Trang HT,
Kim YM, Cho YH, Park D and Hong S: Smad3 regulates E-cadherin via
miRNA-200 pathway. Oncogene. 31:3051–3059. 2012. View Article : Google Scholar
|
|
26
|
Jin B and Robertson KD: DNA
methyltransferases, DNA damage repair, and cancer. Adv Exp Med
Biol. 754:3–29. 2013. View Article : Google Scholar
|
|
27
|
Lim YY, Wright JA, Attema JL, Gregory PA,
Bert AG, Smith E, Thomas D, Lopez AF, Drew PA, Khew-Goodall Y, et
al: Epigenetic modulation of the miR-200 family is associated with
transition to a breast cancer stem-cell-like state. J Cell Sci.
126:2256–2266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Daniel FI, Cherubini K, Yurgel LS, de
Figueiredo MA and Salum FG: The role of epigenetic transcription
repression and DNA methyltransferases in cancer. Cancer.
117:677–687. 2011. View Article : Google Scholar
|
|
29
|
Cao XY, Ma HX, Shang YH, Jin MS, Kong F,
Jia ZF, Cao DH, Wang YP, Suo J and Jiang J: DNA methyltransferase3a
expression is an independent poor prognostic indicator in gastric
cancer. World J Gastroenterol. 20:8201–8208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang J, Wei X, Wu Q, Xu Z, Gu D, Jin Y,
Shen Y, Huang H, Fan H and Chen J: Clinical significance of the
expression of DNA methyltransferase proteins in gastric cancer. Mol
Med Rep. 4:1139–1143. 2011.PubMed/NCBI
|
|
31
|
Dakhlallah D, Batte K, Wang Y,
Cantemir-Stone CZ, Yan P, Nuovo G, Mikhail A, Hitchcock CL, Wright
VP, Nana-Sinkam SP, et al: Epigenetic regulation of miR-17~92
contributes to the pathogenesis of pulmonary fibrosis. Am J Respir
Crit Care Med. 187:397–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi
D, Duan X, Xuan A, Zhang W, Lu J, et al: MicroRNA-152 targets DNA
methyltrans-ferase 1 in NiS-transformed cells via a feedback
mechanism. Carcinogenesis. 34:446–453. 2013. View Article : Google Scholar
|
|
33
|
Liu R, Gu J, Jiang P, Zheng Y, Liu X,
Jiang X, Huang E, Xiong S, Xu F, Liu G, et al: DNMT1-microRNA126
epigenetic circuit contributes to esophageal squamous cell
carcinoma growth via ADAM9-EGFR-AKT signaling. Clin Cancer Res.
21:854–863. 2015. View Article : Google Scholar
|
|
34
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
35
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
